Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. NRF-2019R1A5A2027521), the Korean Fund for Regenerative Medicine (KFRM) grant (the Ministry of Science and ICT, the Ministry of Health & Welfare, No. 22A0104L1), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. NRF-2020R1I1A1A01061824).
References
- American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45(Suppl 1):S17-38. doi: 10.2337/dc22-S002
- Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119. doi: 10.1016/j.diabres.2021.109119
- Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev 2017;13:3-10. doi: 10.2174/1573399812666151016101622
- Tomasiuk JM, Nowakowska-Plaza A, Wislowska M, Gluszko P. Osteoporosis and diabetes - possible links and diagnostic difficulties. Reumatologia 2023;61:294-304. doi: 10.5114/reum/170048
- Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary osteoporosis. Endocr Rev 2022;43:240-313. doi: 10.1210/endrev/bnab028
- Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y, Zhu D. A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment. Front Endocrinol (Lausanne) 2022;13:1052592. doi: 10.3389/fendo.2022.1052592
- Wu YY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. Int J Oral Sci 2015;7:63-72. doi: 10.1038/ijos.2015.2
- Chen SC, Shepherd S, McMillan M, McNeilly J, Foster J, Wong SC, Robertson KJ, Ahmed SF. Skeletal fragility and its clinical determinants in children with type 1 diabetes. J Clin Endocrinol Metab 2019;104:3585-94. doi: 10.1210/jc.2019-00084
- Halper-Stromberg E, Gallo T, Champakanath A, Taki I, Rewers M, Snell-Bergeon J, Frohnert BI, Shah VN. Bone mineral density across the lifespan in patients with type 1 diabetes. J Clin Endocrinol Metab 2020;105:746-53. doi: 10.1210/clinem/dgz153
- Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, Yu Q, Zillikens MC, Gao X, Rivadeneira F. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 2012;27:319-32. doi: 10.1007/s10654-012-9674-x
- Schacter GI, Leslie WD. Diabetes and osteoporosis: part I, epidemiology and pathophysiology. Endocrinol Metab Clin North Am 2021;50:275-85. doi: 10.1016/j.ecl.2021.03.005
- Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, Meier C. Bone microarchitecture and strength in long-standing type 1 diabetes. J Bone Miner Res 2022;37:837-47. doi: 10.1002/jbmr.4517
- Martinez-Montoro JI, Garcia-Fontana B, Garcia-Fontana C, Munoz-Torres M. Evaluation of quality and bone microstructure alterations in patients with type 2 diabetes: a narrative review. J Clin Med 2022;11:2206. doi: 10.3390/jcm11082206
- Sihota P, Yadav RN, Dhaliwal R, Bose JC, Dhiman V, Neradi D, Karn S, Sharma S, Aggarwal S, Goni VG, Mehandia V, Vashishth D, Bhadada SK, Kumar N. Investigation of mechanical, material, and compositional determinants of human trabecular bone quality in type 2 diabetes. J Clin Endocrinol Metab 2021;106:e2271-89. doi: 10.1210/clinem/dgab027
- Thong EP, Herath M, Weber DR, Ranasinha S, Ebeling PR, Milat F, Teede H. Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2018;89:314-23. doi: 10.1111/cen.13761
- Koromani F, Oei L, Shevroja E, Trajanoska K, Schoufour J, Muka T, Franco OH, Ikram MA, Zillikens MC, Uitterlinden AG, Krestin GP, Anastassiades T, Josse R, Kaiser SM, Goltzman D, Lentle BC, Prior JC, Leslie WD, McCloskey E, Lamy O, Hans D, Oei EH, Rivadeneira F. Vertebral fractures in individuals with type 2 diabetes: more than skeletal complications alone. Diabetes Care 2020;43:137-44. doi: 10.2337/dc19-0925
- Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes 1995;44:775-82. doi: 10.2337/diab.44.7.775
- Turner RT, Kalra SP, Wong CP, Philbrick KA, Lindenmaier LB, Boghossian S, Iwaniec UT. Peripheral leptin regulates bone formation. J Bone Miner Res 2013;28:22-34. doi: 10.1002/jbmr.1734
- Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev 2018;98:2133-223. doi:10.1152/physrev.00063.2017
- Pramojanee SN, Phimphilai M, Chattipakorn N, Chattipakorn SC. Possible roles of insulin signaling in osteoblasts. Endocr Res 2014;39:144-51. doi: 10.3109/07435800.2013.879168
- Ma X, Su P, Yin C, Lin X, Wang X, Gao Y, Patil S, War AR, Qadir A, Tian Y, Qian A. The roles of FoxO transcription factors in regulation of bone cells function. Int J Mol Sci 2020;21:692. doi: 10.3390/ijms21030692
- Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, Faugere MC, Aja S, Hussain MA, Bruning JC, Clemens TL. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142:309-19. doi: 10.1016/j.cell.2010.06.002
- Gilbert MP, Pratley RE. The impact of diabetes and diabetes medications on bone health. Endocr Rev 2015;36:194-213. doi: 10.1210/er.2012-1042
- Zhang W, Shen X, Wan C, Zhao Q, Zhang L, Zhou Q, Deng L. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell Biochem Funct 2012;30:297-302. doi:10.1002/cbf.2801
- Wang T, Wang Y, Menendez A, Fong C, Babey M, Tahimic CG, Cheng Z, Li A, Chang W, Bikle DD. Osteoblast-specific loss of IGF1R signaling results in impaired endochondral bone formation during fracture healing. J Bone Miner Res 2015;30:1572-84. doi: 10.1002/jbmr.2510
- Raisingani M, Preneet B, Kohn B, Yakar S. Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. Growth Horm IGF Res 2017;34:13-21. doi: 10.1016/j.ghir.2017.04.003
- Lv F, Cai X, Zhang R, Zhou L, Zhou X, Han X, Ji L. Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes. Osteoporos Int 2021;32:1165-73. doi: 10.1007/s00198-020-05790-6
- Asadipooya K, Uy EM. Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature. J Endocr Soc 2019;3:1799-818. doi: 10.1210/js.2019-00160
- Kerkeni M, Saidi A, Bouzidi H, Letaief A, Ben Yahia S, Hammami M. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients. Diab Vasc Dis Res 2013;10:239-45. doi: 10.1177/1479164112460253
- Oren TW, Botolin S, Williams A, Bucknell A, King KB. Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes. J Rehabil Res Dev 2011;48:1195-210. doi: 10.1682/jrrd.2010.09.0186
- Furst JR, Bandeira LC, Fan WW, Agarwal S, Nishiyama KK, McMahon DJ, Dworakowski E, Jiang H, Silverberg SJ, Rubin MR. Advanced glycation endproducts and bone material strength in type 2 diabetes. J Clin Endocrinol Metab 2016;101:2502-10. doi: 10.1210/jc.2016-1437
- Karim L, Bouxsein ML. Effect of type 2 diabetes-related nonenzymatic glycation on bone biomechanical properties. Bone 2016;82:21-7. doi: 10.1016/j.bone.2015.07.028
- Franke S, Siggelkow H, Wolf G, Hein G. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem 2007;113:154-61. doi: 10.1080/13813450701602523
- Okazaki K, Yamaguchi T, Tanaka K, Notsu M, Ogawa N, Yano S, Sugimoto T. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcif Tissue Int 2012;91:286-96. doi: 10.1007/s00223-012-9641-2
- Notsu M, Yamaguchi T, Okazaki K, Tanaka K, Ogawa N, Kanazawa I, Sugimoto T. Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretion. Endocrinology 2014;155:2402-10. doi: 10.1210/en.2013-1818
- Parwani K, Mandal P. Role of advanced glycation end products and insulin resistance in diabetic nephropathy. Arch Physiol Biochem 2023;129:95-107. doi: 10.1080/13813455.2020.1797106
- Yang S, He Z, Wu T, Wang S, Dai H. Glycobiology in osteoclast differentiation and function. Bone Res 2023;11:55. doi: 10.1038/s41413-023-00293-6
- Miyata T, Kawai R, Taketomi S, Sprague SM. Possible involvement of advanced glycation end-products in bone resorption. Nephrol Dial Transplant 1996;11 Suppl 5:54-7. doi: 10.1093/ndt/11.supp5.54
- Park SY, Choi KH, Jun JE, Chung HY. Effects of advanced glycation end products on differentiation and function of osteoblasts and osteoclasts. J Korean Med Sci 2021;36:e239. doi: 10.3346/jkms.2021.36.e239
- Tanaka K, Yamagata K, Kubo S, Nakayamada S, Sakata K, Matsui T, Yamagishi SI, Okada Y, Tanaka Y. Glycolaldehydemodified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10. Bone 2019;128:115034. doi: 10.1016/j.bone.2019.115034
- Palermo A, D'Onofrio L, Buzzetti R, Manfrini S, Napoli N. Pathophysiology of bone fragility in patients with diabetes. Calcif Tissue Int 2017;100:122-32. doi: 10.1007/s00223-016-0226-3
- Xu J, Yu L, Liu F, Wan L, Deng Z. The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review. Front Immunol 2023;14:1222129. doi: 10.3389/fimmu.2023.1222129
- An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, Jiang ZZ. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol 2023;22:237. doi: 10.1186/s12933-023-01965-7
- Marques-Carvalho A, Kim HN, Almeida M. The role of reactive oxygen species in bone cell physiology and pathophysiology. Bone Rep 2023;19:101664. doi: 10.1016/j.bonr.2023.101664
- Iantomasi T, Romagnoli C, Palmini G, Donati S, Falsetti I, Miglietta F, Aurilia C, Marini F, Giusti F, Brandi ML. Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci 2023;24:3772. doi: 10.3390/ijms24043772
- Cheon YH, Lee CH, Jeong DH, Kwak SC, Kim S, Lee MS, Kim JY. Dual oxidase maturation factor 1 positively regulates RANKL-induced osteoclastogenesis via activating reactive oxygen species and TRAF6-mediated signaling. Int J Mol Sci 2020;21:6416. doi: 10.3390/ijms21176416
- Xuan Y, Wang J, Zhang X, Wang J, Li J, Liu Q, Lu G, Xiao M, Gao T, Guo Y, Cao C, Chen O, Wang K, Tang Y, Gu J. Resveratrol attenuates high glucose-induced osteoblast dysfunction via AKT/GSK3β/FYN-mediated NRF2 activation. Front Pharmacol 2022;13:862618. doi: 10.3389/fphar.2022.862618
- Lamster IB. Diabetes mellitus and oral health: an interprofessional approach. John Wiley & Sons; 2014.
- Mealey BL, Oates TW; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-303. doi: 10.1902/jop.2006.050459
- Pacios S, Andriankaja O, Kang J, Alnammary M, Bae J, de Brito Bezerra B, Schreiner H, Fine DH, Graves DT. Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosis. Am J Pathol 2013;183:1928-35. doi: 10.1016/j.ajpath.2013.08.017